SpringWorks Therapeutics

是其中之一......

• Russell 3000.

SpringWorks Therapeutics 是一家在股票代码 SWTX (US) 下上市的公司。

查看带有其 20 名主要高管的组织结构图

SpringWorks Therapeutics 搜索最多的简介

• Saqib Islam, Chief Executive Officer and Director
• Freda Lewis-Hall, Director
• Julie Hambleton, Director

高管在SpringWorks Therapeutics变化

• Tai-An Lin已作为Chief Scientific Officer加入公司  (新闻发布的2023九月12号).

创建提醒
跟踪 SpringWorks Therapeutics 的高管变动

SpringWorks Therapeutics 拥有 1,861 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。

Popular M&A news in 药店

• MedMen has filed for bankruptcy protection  (公布2024四月28号).
• AstraZeneca has announced the acquisition of Fusion Pharma  (公布2024三月23号).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (公布2024三月19号).

药店 行业的其他推荐联系人

• Ferring Pharmaceuticals 企业 Jean-Frédéric Paulsen - Executive Chairman of the Board
• Amolyt Pharma 企业 Thierry Abribat - Chief Executive Officer
• Menarini Group 企业 Lucia Aleotti - Director

了解更多有关药店行业的信息 >

SpringWorks Therapeutics 的最新新闻稿

• SpringWorks Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights | SpringWorks Therapeutics
• SpringWorks Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Conference | SpringWorks Therapeutics
• SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors | SpringWorks Therapeutics
• SpringWorks Therapeutics to Present Progress Across the Company’s Targeted Oncology Portfolio at Virtual R&D Day | SpringWorks Therapeutics
• SpringWorks Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference | SpringWorks Therapeutics
• SpringWorks Therapeutics Highlights Nirogacestat Clinical Data at the 2022 ASCO Annual Meeting | SpringWorks Therapeutics
• SpringWorks Therapeutics Announces Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase 3 DeFi Trial in Adult Patients with Progressing Desmoid Tumors | SpringWorks Therapeutics
• SpringWorks Therapeutics to Host Virtual R&D Day on June 10, 2022 | SpringWorks Therapeutics
• SpringWorks Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares | SpringWorks Therapeutics
• SpringWorks Therapeutics Announces Pricing of Public Offering of Common Stock | SpringWorks Therapeutics
• View more press releases Close

关于 SpringWorks Therapeutics 的社交媒体

• SpringWorks Therapeutics 在 维基百科、谷歌新闻 和 雅虎财经
• SpringWorks Therapeutics 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Saqib Islam

致电SpringWorks Therapeutics，电话：+1 917...

查看组织结构图

Register to receive your alert

报告错误